PolyPid Ltd.

Symbol: PYPD

NASDAQ

4.5001

USD

Market price today

  • -0.3118

    P/E Ratio

  • 0.0008

    PEG Ratio

  • 7.44M

    MRK Cap

  • 0.00%

    DIV Yield

PolyPid Ltd. (PYPD) Stock Price & Analysis

Shares Outstanding

0M

Gross Profit Margin

0.00%

Operating Profit Margin

0.00%

Net Profit Margin

0.00%

Return on Assets

-1.55%

Return on Equity

-4.50%

Return on Capital Employed

-1.40%

Company general description and statistics

Sector: Healthcare
Industry: Biotechnology
CEO:Ms. Dikla Czaczkes Akselbrad
Full-time employees:59
City:Petah Tikva
Address:18 Hasivim Street
IPO:2020-06-26
CIK:0001611842

PolyPid Ltd., a late-stage biopharma company, develops, manufactures, and commercializes products based on polymer-lipid encapsulation matrix (PLEX) platform to address unmet medical needs. Its lead product candidate is D-PLEX100, which is in Phase III clinical trial for the prevention of sternal (bone) surgical site infections (SSIs), as well as for the prevention of abdominal (soft tissue) SSIs. PolyPid Ltd. was incorporated in 2008 and is headquartered in Petah Tikva, Israel.

Return on Investments

The company's asset efficiency, represented by a robust -1.552% return, is a testament to PolyPid Ltd.'s adeptness in optimizing resource deployment. PolyPid Ltd.'s utilization of its assets to generate profits is strikingly evident through a noteworthy return on equity of -4.504%. Furthermore, the proficiency of PolyPid Ltd. in capital utilization is underscored by a remarkable -1.396% return on capital employed.

Stock Prices

PolyPid Ltd.'s stock prices have been subject to undulating patterns. The peak stock value during this interval surged to $5.09, while its low point bottomed out at $4.8. This variance in figures offers investors a lucid insight into the roller-coaster ride that is PolyPid Ltd.'s stock market.

Liquidity Ratios

Analyzing PYPD liquidity ratios reveals its financial health of the firm. The current ratio of 83.27% gauges short-term asset coverage for liabilities. The quick ratio (76.98%) assesses immediate liquidity, while the cash ratio (76.98%) indicates cash reserves.

cards.indicatorcards.value
Current Ratio83.27%
Quick Ratio76.98%
Cash Ratio76.98%

Profitability Ratios

The effective tax rate stands at -0.29%, revealing its tax efficiency. The net income per EBT, 100.29%, and the EBT per EBIT, 210.75%, provide insights into its earnings hierarchy.

cards.indicatorcards.value
Effective Tax Rate-0.29%
Net Income per EBT100.29%
EBT per EBIT210.75%

Operational Efficiency

Operational metrics shed light on its business agility. With an operating cycle of 0.83, it details the span from stock purchase to revenue. The 1 days it takes to settle debts showcases its creditor relations.

cards.indicatorcards.value
Days of Sales Outstanding77

Cash Flow Ratios

The cash per share value, 3.39, showcases liquidity position.

cards.indicatorcards.value
Cash per Share3.39

Debt and Leverage Ratios

Diving into debt and leverage metrics unveils the company's financial structure. The debt ratio, at 71.05%, highlights its total liabilities relative to assets. With a debt-equity ratio of -5.21, we discern the balance between debt and equity financing. The long-term debt to capitalization, 148.94%, and total debt to capitalization, 123.75%, ratios shed light on its capital structure. An interest coverage of -0.90 indicates its ability to manage interest expenses.

cards.indicatorcards.value
Debt Ratio71.05%
Debt Equity Ratio-5.21
Long Term Debt to Capitalization148.94%
Total Debt to Capitalization123.75%
Interest Coverage-0.90
Company Equity Multiplier-7.33

Per Share Data

Net income per share, -16.99, reflects the portion of profit attributed to each share. The book value per share, -1.49, represents the net asset value distributed per share, while the tangible book value per share, -1.49, excludes intangible assets.

cards.indicatorcards.value
Net Income Per Share-16.99
Book Value Per Share-1.49
Tangible Book Value Per Share-1.49
Shareholders Equity Per Share-1.49
Interest Debt Per Share9.00
Capex Per Share-0.14

Growth Ratios

EBIT growth, 41.20%, and operating income growth, 41.20%, offer insights into operational profitability progression. The net income growth, 39.62%, showcases bottom-line expansion, and the EPS growth, -736.95%, measures the growth in earnings per share.

cards.indicatorcards.value
Gross Profit Growth-5.87%
EBIT Growth41.20%
Operating Income Growth41.20%
Net Income Growth39.62%
EPS Growth-736.95%
EPS Diluted Growth-736.95%
Weighted Average Shares Growth-92.77%
Weighted Average Shares Diluted Growth-92.77%
Operating Cash Flow Growth49.77%
Free Cash Flow Growth51.69%
10-Year Operating CF Growth per Share4.36%
5-Year Operating CF Growth per Share67.38%
3-Year Operating CF Growth per Share-444.57%
10-Year Net Income Growth per Share14.15%
5-Year Net Income Growth per Share-227.29%
3-Year Net Income Growth per Share-360.98%
10-Year Shareholders Equity Growth per Share96.37%
5-Year Shareholders Equity Growth per Share99.19%
3-Year Shareholders Equity Growth per Share-119.65%
Receivables Growth-100.00%
Inventory Growth-100.00%
Asset Growth-40.81%
Book Value per Share Growth-594.69%
Debt Growth-14.21%
R&D Expense Growth-42.31%
SGA Expenses Growth-55.07%

Other Metrics

Venturing into other key metrics unveils diverse facets of financial performance. The enterprise value, 11,506,598.4, captures the company's total value, considering both debt and equity. Income quality, 0.72, assesses the reliability of reported earnings.

cards.indicatorcards.value
Enterprise Value11,506,598.4
Income Quality0.72
Capex to Operating Cash Flow1.14%
Capex to Depreciation-10.76%
Graham Number23.89
Return on Tangible Assets-155.25%
Graham Net Net-8.44
Working Capital-1,219,000
Tangible Asset Value-2,096,000
Net Current Asset Value-11,401,000
Invested Capital-5
Average Receivables149,000
Average Payables956,500
Average Inventory106,500
Days Payables Outstanding155
ROIC-259.84%
ROE11.39%

Valuation Ratios

Exploring the valuation ratios offers insights into perceived market value. The price to book value ratio, -3.55, and the price to book ratio, -3.55, reflect the market's valuation relative to the company's book value.

cards.indicatorcards.value
Price Book Value Ratio-3.55
Price to Book Ratio-3.55
Enterprise Value Multiple-0.06
Price Fair Value-3.55
Price to Tangible Book Ratio-2.55
Enterprise Value Over EBITDA-0.55
EV to Operating Cash Flow-0.67
Earnings Yield-447.19%
Free Cash Flow Yield-326.65%
security
Trusted project
“All information displayed on the site is verified. High quality project and financial performance”
Eugene Alexeev
NumFin Founder and investing enthusiast

Frequently Asked Question

How many company shares are outstanding in 2024?

There are stock number shares outstanding of PolyPid Ltd. (PYPD) on the NASDAQ in 2024.

What is P/E ratio of enterprise in 2024?

The current P/E ratio of enterprise is -0.312 in 2024.

What is the ticker symbol of PolyPid Ltd. stock?

The ticker symbol of PolyPid Ltd. stock is PYPD.

What is company IPO date?

IPO date of PolyPid Ltd. is 2020-06-26.

What is company current share price?

Current share price is 4.500 USD.

What is stock market cap today?

The market cap of stock today is 7441185.000.

What is PEG ratio in 2024?

The current 0.001 is 0.001 in 2024.

What is the number of employees in 2024?

In 2024 the company has 59.